# REGENESIS BIOMEDICAL INC: Form D filing

REGENESIS BIOMEDICAL INC, a biotechnology company in Scottsdale, AZ, filed a Form D with the SEC in 2011. The latest, on June 21, 2011, reports $5.2 million sold of an offering with no set size to 9 investors.

Find out what REGENESIS BIOMEDICAL INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20REGENESIS%20BIOMEDICAL%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=REGENESIS%20BIOMEDICAL%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fregenesis-biomedical-inc-1172973)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20REGENESIS%20BIOMEDICAL%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=REGENESIS%20BIOMEDICAL%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fregenesis-biomedical-inc-1172973)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Arizona](https://specstream.ai/data/form-d/state/arizona): 953 rows, by operating companies, filed since November 1, 2024, $47.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/arizona
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1435 NORTH HAYDEN ROAD, Scottsdale, AZ, 85257
- Phone: 18779704970
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $5,000,001 - $25,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1172973

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jun 21, 2011 | New notice | Indefinite | $5,202,364 | Indefinite | 9 | Jun 2, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1172973/000117297311000005/0001172973-11-000005-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| CHUCK LUNDEN | Director |  |
| VIRGINIA RYBSKI | Executive Officer, Director |  |
| JOHN VORIS | Director |  |
| HENRY NEWMAN | Director |  |
| JACK AHRENS | Director |  |
| PETER SHEEHAN | Director |  |
| TOM GREER | Director |  |
| DENNIS GENGE | Executive Officer |  |

## Other biotechnology companies in Arizona that filed recently

- [Gut-Brain-Axis Therapeutics Inc.](https://specstream.ai/data/form-d/company/gut-brain-axis-therapeutics-inc-1996678) $2 million · Oct 27, 2026
- [Avery Therapeutics, Inc.](https://specstream.ai/data/form-d/company/avery-therapeutics-inc-1708135) $8.5 million · Sep 21, 2026

[Every Form D from the week of Jun 20, 2011](https://specstream.ai/data/form-d/week/2011-06-20) · [All recent filings in Arizona](https://specstream.ai/data/form-d/state/arizona) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what REGENESIS BIOMEDICAL INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).